Eledon Pharmaceuticals (ELDN) Current Leases (2019 - 2026)
Eledon Pharmaceuticals posted quarterly Current Leases of $369000.0 for Q1 2026, up 13.54% year-on-year from $325000.0 in Q1 2025, and up 3.07% on a QoQ basis from $358000.0 in Q4 2025.
Eledon Pharmaceuticals (ELDN) has 8 years of Current Leases data on file, last reported at $369000.0 in Q1 2026.
- For the quarter ending Q1 2026, Current Leases rose 13.54% year-over-year to $369000.0; the trailing twelve-month figure through Mar 2026 stood at $369000.0 (up 13.54% YoY), and the FY2025 full-year result was $358000.0, up 14.01% from the prior year.
- Current Leases for Q1 2026 stood at $369000.0, up from $358000.0 in the prior quarter.
- Across five years, Current Leases topped out at $396000.0 in Q3 2023 and bottomed at $186000.0 in Q3 2024.
- The 5-year median for Current Leases is $346000.0 (2025), against an average of $335058.8.
- The widest annual swing landed in 2022, when Current Leases soared 238.14%; it then tumbled 53.03% in 2024.
- A 5-year view of Current Leases shows it stood at $363000.0 in 2022, then climbed by 5.51% to $383000.0 in 2023, then retreated by 18.02% to $314000.0 in 2024, then rose by 14.01% to $358000.0 in 2025, then increased by 3.07% to $369000.0 in 2026.
- The last three Current Leases figures came in at $369000.0 (Q1 2026), $358000.0 (Q4 2025), and $346000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 83,991.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 7.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 720.00 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 45.66 Mn |
| 10 | Eledon Pharmaceuticals | 419.90 Mn | 203.87 Mn | - | 369,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 369,000.00 |
| Dec 31, 2025 | 358,000.00 |
| Sep 30, 2025 | 346,000.00 |
| Jun 30, 2025 | 336,000.00 |
| Mar 31, 2025 | 325,000.00 |
| Dec 31, 2024 | 314,000.00 |
| Sep 30, 2024 | 186,000.00 |
| Jun 30, 2024 | 269,000.00 |
| Mar 31, 2024 | 284,000.00 |
| Dec 31, 2023 | 383,000.00 |
| Sep 30, 2023 | 396,000.00 |
| Jun 30, 2023 | 390,000.00 |
| Mar 31, 2023 | 384,000.00 |
| Dec 31, 2022 | 363,000.00 |
| Sep 30, 2022 | 378,000.00 |
| Jun 30, 2022 | 287,000.00 |
| Mar 31, 2022 | 328,000.00 |
| Dec 31, 2021 | 369,000.00 |
| Sep 30, 2021 | 177,000.00 |
| Jun 30, 2021 | 179,000.00 |
| Mar 31, 2021 | 97,000.00 |
| Dec 31, 2020 | 144,000.00 |
| Sep 30, 2020 | 191,000.00 |
| Jun 30, 2020 | 188,000.00 |
| Mar 31, 2020 | 184,000.00 |
| Dec 31, 2019 | 180,000.00 |
| Sep 30, 2019 | 177,000.00 |
| Jun 30, 2019 | 173,000.00 |
| Mar 31, 2019 | 170,000.00 |